Franz-Josef Meyer-Almes

Title: Franz-Josef Meyer-Almes: Innovator in HDAC Inhibitors

Introduction

Franz-Josef Meyer-Almes is a notable inventor based in Otzberg-Lengfeld, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of selective HDAC8 inhibitors. His work focuses on small molecule compounds that have potential therapeutic applications.

Latest Patents

Meyer-Almes holds a patent for "Selective HDAC8 inhibitors and their uses." This invention relates to small molecule compounds based on benzopyrimido- or benzoimidazo-thiazin-imine, along with their synthesis intermediates. These compounds are particularly useful as HDAC inhibitors, specifically targeting HDAC8. The patent also discusses their application in cancer treatment and as therapeutic agents for eukaryotic parasites.

Career Highlights

Throughout his career, Meyer-Almes has worked with esteemed institutions such as Hochschule Darmstadt. He has also collaborated with Dr. Felix Jäger and Dr. Stefan Drinkuth at their laboratory, contributing to various research projects and innovations in the field.

Collaborations

Meyer-Almes has collaborated with notable colleagues, including Christian Meyners and Alexander Kleinschek. Their joint efforts have further advanced the research and development of HDAC inhibitors.

Conclusion

Franz-Josef Meyer-Almes is a distinguished inventor whose work on HDAC8 inhibitors has the potential to impact cancer treatment and therapeutic approaches for eukaryotic parasites. His contributions to medicinal chemistry are noteworthy and continue to inspire further research in the field.